TY - JOUR
T1 - A Comparative Analysis of Current Lipid Treatment Guidelines
T2 - Nothing Stands Still
AU - Tibrewala, Anjan
AU - Jivan, Arif
AU - Oetgen, William J.
AU - Stone, Neil J.
N1 - Publisher Copyright:
© 2018 American College of Cardiology Foundation
PY - 2018/2/20
Y1 - 2018/2/20
N2 - Lipid treatment guidelines have continued to evolve as new evidence emerges. We sought to review similarities and differences of 5 lipid treatment guidelines from the American College of Cardiology/American Heart Association, Canadian Cardiovascular Society, European Society for Cardiology/European Atherosclerosis Society, U.S. Preventive Services Task Force, and U.S. Veterans Affairs/Department of Defense. All guidelines utilize rigorous evidentiary review, highlight statin therapy for primary and secondary prevention of atherosclerotic cardiovascular disease, and emphasize a clinician-patient risk discussion. However, there are differences in statin intensities, use of risk estimators, treatment of specific patient subgroups, and consideration of safety concerns. Clinicians should understand these similarities and differences in current and future guideline recommendations when considering if and how to treat their patients with statin therapy.
AB - Lipid treatment guidelines have continued to evolve as new evidence emerges. We sought to review similarities and differences of 5 lipid treatment guidelines from the American College of Cardiology/American Heart Association, Canadian Cardiovascular Society, European Society for Cardiology/European Atherosclerosis Society, U.S. Preventive Services Task Force, and U.S. Veterans Affairs/Department of Defense. All guidelines utilize rigorous evidentiary review, highlight statin therapy for primary and secondary prevention of atherosclerotic cardiovascular disease, and emphasize a clinician-patient risk discussion. However, there are differences in statin intensities, use of risk estimators, treatment of specific patient subgroups, and consideration of safety concerns. Clinicians should understand these similarities and differences in current and future guideline recommendations when considering if and how to treat their patients with statin therapy.
KW - atherosclerotic cardiovascular disease
KW - cholesterol
KW - lipid
KW - primary prevention
KW - secondary prevention
KW - statin
UR - http://www.scopus.com/inward/record.url?scp=85044854832&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85044854832&partnerID=8YFLogxK
U2 - 10.1016/j.jacc.2017.12.025
DO - 10.1016/j.jacc.2017.12.025
M3 - Review article
C2 - 29447742
AN - SCOPUS:85044854832
VL - 71
SP - 794
EP - 799
JO - Journal of the American College of Cardiology
JF - Journal of the American College of Cardiology
SN - 0735-1097
IS - 7
ER -